Phase I Clinical Trial of a Genetically Modified Oncolytic Vaccinia Virus GL-ONC1 With Green Fluorescent Protein Imaging

被引：7

作者：

Biondo, A. ^{[1
]}

Pedersen, J. V. ^{[1
]}

Karapanagiotou, E. M. ^{[2
]}

Tunariu, N. ^{[3
]}

Mansfield, D. ^{[4
]}

Sassi, S. ^{[5
]}

Corral, J. ^{[1
]}

Yap, T. A. ^{[1
]}

de Bono, J. S. ^{[1
]}

Harrington, K. J. ^{[6
]}

机构：

[1] Royal Marsden Hosp, Inst Canc Res, Drug Dev Unit, Sutton, Surrey, England

[2] Royal Marsden Hosp, Inst Canc Res, Head & Neck Unit, London, England

[3] Royal Marsden Hosp, Inst Canc Res, Clin MRI Unit, London, England

[4] Targeted Therapy Team, Inst Canc Res, London, England

[5] Royal Marsden Hosp, Inst Canc Res, Joint Dept Phys, Sutton, Surrey, England

[6] Royal Marsden Hosp, Inst Canc Res, Head & Neck Unit, London SW3 6JJ, England

来源：

关键词：

D O I：

10.1016/S0959-8049(11)70870-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：S162 / S162

页数：1